Overall, our results indicate that GSK3α functions as an oncogene in NSCLC, by regulating stabilization and expression of HIF1α in an independent manner via the PHDs-pVHL signaling pathway. This evidence concerns the gene HIF1A and non-small cell lung carcinoma.